This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Tlc Biopharmaceuticals, Inc., Taiwan Liposome Company, Ltd., Taiwan Lipsome Company, Ltd.. Active years: 2012-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 32 
2 out of 29 
1 out of 2 Years Active: 2012-2021
Title: **Innovations of Yung-Hsu Chan in Pharmaceutical Compositions**
Introduction
Yung-Hsu Chan is a notable inventor based in Taipei, Taiwan, known for his significant contributions to the field of pharmaceutical innovations. With a total of three patents to his name, his work primarily revolves around developing advanced methods for treating cancer with reduced side effects.
Latest Patents
Yung-Hsu Chan's latest patents focus on pharmaceutical compositions comprising hydrophobic camptothecin derivatives. One of his key innovations is a method that utilizes a topoisomerase I inhibitor for the treatment of cancer, specifically aimed at minimizing bone marrow suppression. This method involves administering an effective amount of a pharmaceutical composition, which includes at least one hydrophobic topoisomerase I inhibitor, or its pharmaceutically acceptable salt, combined with at least one polyethylene glycol (PEG) conjugated phospholipid. The composition is crafted with a precise molar ratio of the PEG conjugated phospholipid to the hydrophobic topoisomerase I inhibitor, ranging from about 0.45:1 to approximately 1.05:1.
Additionally, another notable invention from Chan is a pharmaceutical composition that integrates at least one hydrophobic camptothecin derivative or its pharmaceutically acceptable salt alongside PEG conjugated phospholipids. This composition presents a viable method to inhibit cancer cells in patients, offering a promising avenue for improved cancer treatment protocols.
Career Highlights
Yung-Hsu Chan has significantly contributed to the biopharmaceutical industry. Throughout his career, he has worked with esteemed companies, including TLC Biopharmaceuticals, Inc. and Taiwan Liposome Company, Ltd. His role in these organizations has allowed him to merge his innovative ideas with practical applications in drug development.
Collaborations
In his professional journey, Yung-Hsu Chan has collaborated with prominent individuals such as Yun-Long Tseng and Keelung Hong. These partnerships have fostered a collaborative environment conducive to innovation and have played a vital role in his research and development efforts.
Conclusion
Yung-Hsu Chan is a distinguished inventor whose work in pharmaceutical compositions showcases his commitment to advancing cancer treatments. With three patents to his credit and a focus on reducing treatment-related side effects, Chan's contributions are essential to the ongoing evolution of effective and safer cancer therapies. His innovative spirit continues to inspire advancements in the field, highlighting the importance of research and development in healthcare innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile